Jean Bousquet to Rhinitis, Allergic
This is a "connection" page, showing publications Jean Bousquet has written about Rhinitis, Allergic.
Connection Strength
8.518
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020 10; 75(10):2440-2444.
Score: 0.503
-
[Adaptation of the General Data Protection Regulation (GDPR) to a smartphone app for rhinitis and asthma (MASK-air®)]. Rev Mal Respir. 2019 Nov; 36(9):1019-1031.
Score: 0.470
-
Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care? J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2511-2523.
Score: 0.466
-
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018 12; 48(12):1640-1653.
Score: 0.434
-
[MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity]. Tuberk Toraks. 2018 Jun; 66(2):176-181.
Score: 0.428
-
Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries. Int Arch Allergy Immunol. 2018; 176(3-4):181-188.
Score: 0.426
-
Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. Allergy. 2018 09; 73(9):1763-1774.
Score: 0.422
-
Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1726-1732.e6.
Score: 0.419
-
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy. 2018 02; 73(2):505-510.
Score: 0.409
-
Adaptation of the Score for Allergic Rhinitis in the Chinese Population: Psychometric Properties and Diagnostic Accuracy. Int Arch Allergy Immunol. 2017; 173(4):213-224.
Score: 0.406
-
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy. 2018 Jan; 73(1):77-92.
Score: 0.406
-
[ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina]. Rev Alerg Mex. 2017 Jul-Sep; 64(3):298-308.
Score: 0.401
-
Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy. 2017 Aug; 72(8):1261-1266.
Score: 0.393
-
[ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle]. Tuberk Toraks. 2017 Mar; 65(1):32-40.
Score: 0.392
-
The multimorbid polysensitized phenotype is associated with the severity of allergic diseases. J Allergy Clin Immunol. 2017 04; 139(4):1407-1408.
Score: 0.392
-
Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017 Jun; 72(6):857-865.
Score: 0.392
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus. Allergy. 2021 08; 76(8):2354-2366.
Score: 0.131
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
Score: 0.124
-
ARIA masterclass 2018: From guidelines to real-life implementation. Rhinology. 2019 Oct 01; 57(5):392-399.
Score: 0.117
-
Identifying an effective mobile health application for the self-management of allergic rhinitis and asthma in Australia. J Asthma. 2020 10; 57(10):1128-1139.
Score: 0.116
-
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol. 2019 07; 144(1):135-143.e6.
Score: 0.113
-
Rhinology future trends: 2017 EUFOREA debate on allergic rhinitis. Rhinology. 2019 Feb 01; 57(1):49-56.
Score: 0.112
-
Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy. 2019 04; 74(4):815-818.
Score: 0.111
-
Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1752-1755.e3.
Score: 0.105
-
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017 Dec; 47(12):1526-1533.
Score: 0.102
-
Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China. Sci Rep. 2017 08 24; 7(1):9286.
Score: 0.101
-
Allergen immunotherapy in allergic rhinitis: current use and future trends. Expert Rev Clin Immunol. 2017 09; 13(9):897-906.
Score: 0.100
-
Computational analysis of multimorbidity between asthma, eczema and rhinitis. PLoS One. 2017; 12(6):e0179125.
Score: 0.100
-
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct; 140(4):950-958.
Score: 0.100
-
Assessment of thunderstorm-induced asthma using Google Trends. J Allergy Clin Immunol. 2017 09; 140(3):891-893.e7.
Score: 0.100
-
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017 Sep; 72(9):1297-1305.
Score: 0.100
-
Sex-Related Allergic Rhinitis Prevalence Switch from Childhood to Adulthood: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2017; 172(4):224-235.
Score: 0.099
-
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1418-1429.
Score: 0.028